Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Amrita Therapeutics Ltd.
DescriptionP53 tumor suppressor peptide derived from Mycobacterium tuberculosis protein MPT63
Molecular Target p53 ; Beta-catenin (CTNNB1)
Mechanism of Actionp53 activator
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today